Homology Medicines Inc
NASDAQ:QTTB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.13
50.59
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Homology Medicines Inc
Wall Street
Price Targets
QTTB Price Targets Summary
Homology Medicines Inc
According to Wall Street analysts, the average 1-year price target for
QTTB
is 88.06 USD
with a low forecast of 68.68 USD and a high forecast of 105 USD.
QTTB Last Price Targets
Homology Medicines Inc
The latest public price target was made on Oct 16, 2024 by
Jay Olson
from
Oppenheimer
,
who expects
QTTB
stock to
rise by 2 128%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Jay Olson
Oppenheimer
|
80
USD
Upside 2 128% |
2 months ago
Oct 16, 2024
|
Oppenheimer Reiterates Outperform Rating on Q32 Bio Inc. (QTTB)
StreetInsider
|
Derek Archila
Wells Fargo
|
95
USD
Upside 2 546% |
3 months ago
Sep 11, 2024
|
Wells Fargo Starts Q32 Bio Inc. (QTTB) at Overweight
StreetInsider
|
|
Thomas Smith
Leerink Partners
|
54
USD
Upside 1 404% |
7 months ago
May 21, 2024
|
Q32 Bio initiated with an Outperform at Leerink
TheFly
|
|
Jay Olson
Oppenheimer
|
50
USD
Upside 1 293% |
8 months ago
Apr 10, 2024
|
Oppenheimer Starts Q32 Bio Inc. (QTTB) at Outperform
StreetInsider
|
Christopher Raymond
Raymond James
|
45
USD
Upside 1 153% |
8 months ago
Apr 2, 2024
|
Q32 Bio initiated with an Overweight at Piper Sandler
TheFly
|
Allison Bratzel
Piper Sandler
|
45
USD
Upside 1 153% |
8 months ago
Apr 2, 2024
|
Piper Sandler Starts Q32 Bio Inc. (QTTB) at Overweight, 'we would be buyers here'
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is QTTB's stock price target?
Price Target
88.06
USD
According to Wall Street analysts, the average 1-year price target for
QTTB
is 88.06 USD
with a low forecast of 68.68 USD and a high forecast of 105 USD.
You don't have any saved screeners yet
